Talvard-Balland, N., Braun, L.M., Zwick, M., Engel, H., Hartmann, A., Duquesne, S., Geoffroy, A., Acerbis, A., Ehmann, J., Koellerer, C., Rettig, A.R., Moschallski, K., Brummer, T., Illert, A.L., Schramm, M.A., Cheng, Y., Köttgen, A., Duyster, J., Börries, M., Schmitt-Graeff, A., Pahl, H.L., Köhler, N., Wertheimer, T., Kuchroo, V.K. und Zeiser, R. (2025) Oncogene induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice [cd]. Freiburg: Universität. doi:10.1172/jci177460.

Talvard-Balland, Nana, Lukas M. Braun, Melissa Zwick, Helena Engel, Alina Hartmann, Sandra Duquesne, Andrieux Geoffroy, Andrea Acerbis, Jule Ehmann, Christoph Koellerer, Andrés Rudolf Rettig, Kevin Moschallski, Tilman Brummer, Anna Lena Illert, Markus A. Schramm, Yurong Cheng, Anna Köttgen, Justus Duyster, Melanie Börries, Annette Schmitt-Graeff, Heike L. Pahl, Natalie Köhler, Tobias Wertheimer, Vijay K. Kuchroo, und Robert Zeiser. Oncogene induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice. Cd. Freiburg: Universität, [2025?], Freiburg: Universität, [2025?]. https://doi.org/10.1172/jci177460.

Talvard-Balland, N., Braun, L. M., Zwick, M., Engel, H., Hartmann, A., Duquesne, S., Geoffroy, A., Acerbis, A., Ehmann, J., Koellerer, C., Rettig, A. R., Moschallski, K., Brummer, T., Illert, A. L., Schramm, M. A., Cheng, Y., Köttgen, A., Duyster, J., Börries, M., Schmitt-Graeff, A., Pahl, H. L., Köhler, N., Wertheimer, T., Kuchroo, V. K., & Zeiser, R. (ca. 2025). Oncogene induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice [Cd]. Universität. https://doi.org/10.1172/jci177460

Talvard-Balland, N., L. M. Braun, M. Zwick, H. Engel, A. Hartmann, S. Duquesne, A. Geoffroy, A. Acerbis, J. Ehmann, C. Koellerer, A. R. Rettig, K. Moschallski, T. Brummer, A. L. Illert, M. A. Schramm, Y. Cheng, A. Köttgen, J. Duyster, M. Börries, A. Schmitt-Graeff, H. L. Pahl, N. Köhler, T. Wertheimer, V. K. Kuchroo, und R. Zeiser. Oncogene induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice. cd, Universität, 2025, https://doi.org/10.1172/jci177460.

TALVARD-BALLAND, Nana, Lukas M. BRAUN, Melissa ZWICK, Helena ENGEL, Alina HARTMANN, Sandra DUQUESNE, Andrieux GEOFFROY, Andrea ACERBIS, Jule EHMANN, Christoph KOELLERER, Andrés Rudolf RETTIG, Kevin MOSCHALLSKI, Tilman BRUMMER, Anna Lena ILLERT, Markus A. SCHRAMM, Yurong CHENG, Anna KÖTTGEN, Justus DUYSTER, Melanie BÖRRIES, Annette SCHMITT-GRAEFF, Heike L. PAHL, Natalie KÖHLER, Tobias WERTHEIMER, Vijay K. KUCHROO und Robert ZEISER, 2025. Oncogene induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice. Freiburg: Universität